Cargando…
Discovery of drug lead compounds for Anti-Alzheimer's disease on the basis of synaptic plasticity
Alzheimer's disease (AD) is a progressive neurodegenerative disease commonly seen in the middle-aged and the elder. Its clinical presentations are mainly memory impairment and cognitive impairment. Its cardinal pathological features are the deposition of extracellular Amyloid-β (Aβ), intracellu...
Autores principales: | Wang, Heyu, Tang, Quan, Xue, Yanyu, Gao, Xiaoqian, Zhang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412905/ https://www.ncbi.nlm.nih.gov/pubmed/37576278 http://dx.doi.org/10.1016/j.heliyon.2023.e18396 |
Ejemplares similares
-
Signaling abnormality leading to excessive/aberrant synaptic plasticity in Alzheimer's disease
por: Kawabata, Shigeki
Publicado: (2022) -
Mesua beccariana (Clusiaceae), A Source of Potential Anti-cancer Lead Compounds in Drug Discovery
por: Teh, Soek Sin, et al.
Publicado: (2012) -
Hepatocyte Growth Factor in Synaptic Plasticity and Alzheimer's Disease
por: Sharma, Shiv K.
Publicado: (2010) -
Targeting Synaptic Plasticity in Experimental Models of Alzheimer’s Disease
por: Mango, Dalila, et al.
Publicado: (2019) -
Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Ismaili, Lhassane
Publicado: (2022)